The Current Price For Mesoblast Ltd ADR (NASDAQ: MESO): And Is It Worth Investing In?

During the last session, Mesoblast Ltd ADR (NASDAQ:MESO)’s traded shares were 0.32 million, with the beta value of the company hitting 3.49. At the end of the trading day, the stock’s price was $6.24, reflecting an intraday gain of 1.46% or $0.09. The 52-week high for the MESO share is $10.24, that puts it down -64.1 from that peak though still a striking 74.2% gain since the share price plummeted to a 52-week low of $1.61. The company’s market capitalization is $712.11M, and the average trade volume was 2.23 million shares over the past three months.

Mesoblast Ltd ADR (NASDAQ:MESO) trade information

Mesoblast Ltd ADR (MESO) registered a 1.46% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.46% in intraday trading to $6.24, hitting a weekly high. The stock’s 5-day price performance is 19.77%, and it has moved by 78.80% in 30 days. Based on these gigs, the overall price performance for the year is -9.30%.

Mesoblast Ltd ADR (MESO) estimates and forecasts

Statistics show that Mesoblast Ltd ADR has outperformed its competitors in share price, compared to the industry in which it operates. Mesoblast Ltd ADR (MESO) shares have gone up 151.61% during the last six months, with a year-to-date growth rate more than the industry average at 35.45% against 12.90. In the rating firms’ projections, revenue will decrease -2.70% compared to the previous financial year.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -7.89%. While earnings are projected to return 12.16% in 2024, the next five years will return 48.80% per annum.

MESO Dividends

Mesoblast Ltd ADR is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Mesoblast Ltd ADR (NASDAQ:MESO)’s Major holders